Asthma that is unresponsive to usual care.
Chapman
Kenneth R
KR
Asthma and Airway Centre, University Health Network, Toronto Western Hospital and University of Toronto, Toronto, Ont.
McIvor
Andrew
A
D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000069444:Omalizumab; D010353:Patient Education as Topic; D012017:Referral and Consultation; D012129:Respiratory Function Tests; D012720:Severity of Illness Index; D013256:Steroids / Q000627:therapeutic use; D017211:Treatment Failure
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001993:Bronchodilator Agents; D013256:Steroids; D000069444:Omalizumab